Analysts: Abiomed Inc (ABMD.OQ)
ABMD.OQ on NASDAQ Stock Exchange Global Select Market
24.15USD
1 Aug 2013
24.15USD
1 Aug 2013
Price Change (% chg)
$-0.93 (-3.71%)
$-0.93 (-3.71%)
Prev Close
$25.08
$25.08
Open
$25.22
$25.22
Day's High
$25.22
$25.22
Day's Low
$22.94
$22.94
Volume
422,319
422,319
Avg. Vol
118,161
118,161
52-wk High
$25.24
$25.24
52-wk Low
$11.82
$11.82
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.07 | March | 1 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 3 | 3 | 4 | 4 |
| (2) OUTPERFORM | 2 | 2 | 2 | 2 |
| (3) HOLD | 3 | 3 | 3 | 3 |
| (4) UNDERPERFORM | 2 | 2 | 2 | 2 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.40 | 2.40 | 2.27 | 2.27 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 7 | 44.10 | 45.40 | 43.00 | 44.95 |
| Quarter Ending Dec-13 | 7 | 45.99 | 47.50 | 43.60 | 46.95 |
| Year Ending Mar-13 | 11 | 156.34 | 158.14 | 155.10 | -- |
| Year Ending Mar-14 | 10 | 183.79 | 188.00 | 180.82 | 184.62 |
| Year Ending Mar-15 | 8 | 208.82 | 223.54 | 184.50 | 218.60 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 9 | 0.07 | 0.11 | 0.05 | 0.12 |
| Quarter Ending Dec-13 | 9 | 0.08 | 0.11 | 0.06 | 0.16 |
| Year Ending Mar-13 | 12 | 0.35 | 0.37 | 0.32 | -- |
| Year Ending Mar-14 | 9 | 0.32 | 0.44 | 0.27 | 0.44 |
| Year Ending Mar-15 | 7 | 0.59 | 0.88 | 0.49 | 0.89 |
| LT Growth Rate (%) | 2 | 37.50 | 55.00 | 20.00 | 25.00 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 41.95 | 43.67 | 1.72 | 4.11 |
| Quarter Ending Dec-12 | 38.04 | 38.25 | 0.21 | 0.54 |
| Quarter Ending Sep-12 | 37.47 | 37.42 | 0.05 | 0.14 |
| Quarter Ending Jun-12 | 36.88 | 38.78 | 1.91 | 5.17 |
| Quarter Ending Mar-12 | 34.92 | 37.34 | 2.42 | 6.93 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.07 | 0.09 | 0.02 | 22.28 |
| Quarter Ending Dec-12 | 0.07 | 0.07 | 0.00 | 2.94 |
| Quarter Ending Sep-12 | 0.05 | 0.13 | 0.08 | 141.64 |
| Quarter Ending Jun-12 | 0.03 | 0.08 | 0.05 | 166.67 |
| Quarter Ending Mar-12 | 0.06 | 0.06 | 0.00 | 2.28 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 44.10 | 44.10 | 44.10 | 44.10 | 44.95 |
| Quarter Ending Dec-13 | 45.99 | 45.99 | 45.99 | 45.99 | 46.95 |
| Year Ending Mar-13 | 156.34 | -- | -- | -- | -- |
| Year Ending Mar-14 | 183.79 | 183.79 | 183.79 | 183.81 | 184.62 |
| Year Ending Mar-15 | 208.82 | 208.82 | 208.82 | 208.82 | 218.60 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.07 | 0.07 | 0.08 | 0.07 | 0.12 |
| Quarter Ending Dec-13 | 0.08 | 0.08 | 0.08 | 0.08 | 0.16 |
| Quarter Ending Mar-13 | 0.35 | -- | -- | -- | -- |
| Quarter Ending Mar-14 | 0.32 | 0.32 | 0.32 | 0.32 | 0.44 |
| Quarter Ending Mar-15 | 0.59 | 0.59 | 0.59 | 0.60 | 0.89 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Mar-13 | -- | -- | -- | -- |
| Year Ending Mar-14 | 0 | 0 | 0 | 0 |
| Year Ending Mar-15 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 1 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 1 |
| Year Ending Mar-13 | -- | -- | -- | -- |
| Year Ending Mar-14 | 0 | 0 | 0 | 0 |
| Year Ending Mar-15 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$49.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates